G673-0681 Screening compound: 2-[6-oxo-3-(piperidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide

G673-0681 Screening compound: 2-[6-oxo-3-(piperidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide
G673-0681 Screening compound: 2-[6-oxo-3-(piperidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G673-0681
2-[6-oxo-3-(piperidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G673-0681

Molecular Formula

C26H31N5O3 (C26 H31 N5 O3)

Compound Name

2-[6-oxo-3-(piperidine-1-carbonyl)-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide

IUPAC name

2-[6-oxo-3-(piperidine-1-carbonyl)-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxalin-5-yl]-N-[(pyridin-2-yl)methyl]acetamide

SMILES

O=C(CN1c(cc(cc2)C(N3CCCCC3)=O)c2N(CCCC2)C2C1=O)NCc1ncccc1

InChI

InChI=1S/C26H31N5O3/c32-24(28-17-20-8-2-4-12-27-20)18-31-23-16-19(25(33)29-13-5-1-6-14-29)10-11-21(23)30-15-7-3-9-22(30)26(31)34/h2,4,8,10-12,16,22H,1,3,5-7,9,13-15,17-18H2,(H,28,32)/t22-/m0/s1

InChI Key

CTAQPPCPVXFGLL-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27150569

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.557

Distribution Coefficient, logD

1.556

Water Solubility, LogSw

-2.40

Polar Surface Area

68.455

Acid Dissociation Constant (pKa)

12.80

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.20

G673-0681 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Lipid Metabolism Library (9174 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G673-0681 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G673-0681?
Check Price and Availability of G673-0681, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G673-0681 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G673-0681
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G673-0681
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G673-0681 available by request